6[1]Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:pmgnotic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular aysfunction.Circulation,1997,96:509-516.
7[2]Chen HH,Bumett JC.Natriuretic peptides in the pathophysiology of congestive heart failure.Curr Cardiol Rep,2000,2:198-205.
8[3]Bittner V,Weiner DH,Yusuf S,et al.Prediction of mortality and morbidity with a 6 minute walk test in patients with left ventricular dysfunction.SOLVD Investigtors.JAMA,1993,270:1702-1707.
9[5]Bay M,Kirk V,Parner J,et al.NT-proBNP:a new diagnostic screening tool to defferentiate between patients with normal and reduced left ventricular systolic function.Heart,2003,89:150-154.
10[6]Hobbs FD,Davis RC,Roalfe AK,et al.Reliability of N-terminal pro-brain nftriuretic peptide assay in diagnosis of heart failure:cohort study in representative and high risk community populations,BMJ,2002,324:1498.